Showing 63,041 - 63,060 results of 63,536 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((ng decrease) OR (nn decrease)) ))', query time: 1.36s Refine Results
  1. 63041

    Table 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  2. 63042

    Table_2_Decoupling the Effects of the Amyloid Precursor Protein From Amyloid-β Plaques on Axonal Transport Dynamics in the Living Brain.DOCX by Christopher S. Medina (8070011)

    Published 2019
    “…Paired T-tests within-group between time points (p = 0.01 FDR corrected) support the impression that both plaque alone and APP<sup>SwInd</sup> expression alone alter transport rates and destination of Mn<sup>2+</sup> accumulation. …”
  3. 63043

    Video_1_Decoupling the Effects of the Amyloid Precursor Protein From Amyloid-β Plaques on Axonal Transport Dynamics in the Living Brain.MP4 by Christopher S. Medina (8070011)

    Published 2019
    “…Paired T-tests within-group between time points (p = 0.01 FDR corrected) support the impression that both plaque alone and APP<sup>SwInd</sup> expression alone alter transport rates and destination of Mn<sup>2+</sup> accumulation. …”
  4. 63044

    Table_1_Decoupling the Effects of the Amyloid Precursor Protein From Amyloid-β Plaques on Axonal Transport Dynamics in the Living Brain.pdf by Christopher S. Medina (8070011)

    Published 2019
    “…Paired T-tests within-group between time points (p = 0.01 FDR corrected) support the impression that both plaque alone and APP<sup>SwInd</sup> expression alone alter transport rates and destination of Mn<sup>2+</sup> accumulation. …”
  5. 63045

    Image 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  6. 63046

    Image 11_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  7. 63047

    Image 7_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  8. 63048

    Image 8_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  9. 63049

    Image 6_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  10. 63050

    Data_Sheet_1_Decoupling the Effects of the Amyloid Precursor Protein From Amyloid-β Plaques on Axonal Transport Dynamics in the Living Brain.pdf by Christopher S. Medina (8070011)

    Published 2019
    “…Paired T-tests within-group between time points (p = 0.01 FDR corrected) support the impression that both plaque alone and APP<sup>SwInd</sup> expression alone alter transport rates and destination of Mn<sup>2+</sup> accumulation. …”
  11. 63051

    Image 4_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  12. 63052

    Image 9_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  13. 63053

    Image 12_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  14. 63054

    Image 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.jpeg by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  15. 63055

    Table 3_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  16. 63056

    Image 13_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  17. 63057

    Table 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  18. 63058

    Image 10_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  19. 63059

    Image 5_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  20. 63060

    Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod by Zi-Ye Song (731226)

    Published 2015
    “…Eight relapsed patients demonstrated greater percentages of CD4<sup>+</sup>TCM than 15 non-relapsed patients at 3 and 6 months (<i>p</i>=0.0051 and <i>p</i>=0.0088, respectively). The IL17-, IL9-, and IL4-producing CD4<sup>+</sup>T cell percentages were significantly higher at pre-treatment in MS patients compared with HCs (<i>p</i><0.01 for all), while the IL17-producing CD4<sup>+</sup>T cell percentages tended to show a transient increase at 2 weeks of fingolimod therapy (<i>p<sup>corr</sup></i>=0.0834).…”